Rocket Pharmaceuticals (RCKT) Goodwill & Intangibles (2018 - 2025)
Rocket Pharmaceuticals (RCKT) has disclosed Goodwill & Intangibles for 8 consecutive years, with $64.4 million as the latest value for Q4 2025.
- Quarterly Goodwill & Intangibles changed 0.0% to $64.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.4 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $64.4 million for FY2025, 0.0% changed from the prior year.
- Goodwill & Intangibles hit $64.4 million in Q4 2025 for Rocket Pharmaceuticals, roughly flat from $64.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $64.9 million in Q4 2022 to a low of $30.8 million in Q1 2021.
- Historically, Goodwill & Intangibles has averaged $52.7 million across 5 years, with a median of $64.3 million in 2023.
- Biggest five-year swings in Goodwill & Intangibles: soared 110.69% in 2022 and later dropped 0.95% in 2023.
- Year by year, Goodwill & Intangibles stood at $30.8 million in 2021, then surged by 110.69% to $64.9 million in 2022, then dropped by 0.95% to $64.3 million in 2023, then grew by 0.07% to $64.4 million in 2024, then changed by 0.0% to $64.4 million in 2025.
- Business Quant data shows Goodwill & Intangibles for RCKT at $64.4 million in Q4 2025, $64.4 million in Q3 2025, and $64.3 million in Q2 2025.